PD-L1 is not only expressed in the tumour microenvironment of gliomas112,122,123 but also elevated in circulating APCs in patients with glioma.124 This of course may indicate biological activity, even if the therapeutic antibody does not reach sufficient intra-tumoural levels. This evidence concerns the gene CD274 and neoplasm.